Digoxin 0 point 25 mg tab,Tab Metoprolol XL 25 mg,Dobutamine HCI 250 mg 5 ml Inj,Aspirin 75 mg tab,
Indian Army
POONCH, JAMMU & KASHMIR
Bid Publish Date
04-Nov-2024, 9:09 am
Bid End Date
25-Nov-2024, 10:00 am
Value
₹9,09,920
Progress
Quantity
52004
Category
Digoxin 0 pt 5 mg 2 ml Inj
Bid Type
Two Packet Bid
A tender has been published for Indian Army Digoxin 0 pt 5 mg 2 ml Inj, Vasopressin 20 units slash ml Inj, Clonidine 100 mcg Tab, Hydrochlorthiazide 25 mg, Labetalol HCl 20 ml slash 4ml Inj, Phenylephrine 10 mg 1ml Inj, Tab Prazocin 5 mg sustained release slash slow release, Tab Methylodopa 250mg, Metoprolol 12 pt 5mg Tab, Nebivolol 50 mg Tab, Propranolol 20 mg SR Tab, Tab Amlodipine 10mg, Nicorandl 5 mgTab, Triamcinalone Acetate 1 percent for oral use Tube of 5 gm, Adapalene 0 pt 1 percent Tube of 15 gm, 0 pt 05 percent Halobetasol Propionate plus 3 percent Salicylic acid ointment tube of 15 gm, Benzylperoxide gel 2pt 5 percent Tube of 20 gms, Lot calamine 8 percent with10 percent light Liquid Paraffin bott of 50ml, Betamethasone Dipropionate USP 5mg and Gentamycin Sulphate 1mg slash gm Tube of 5gm, Zinc Oxide slash Titanium Dioxide Bott SPF 50 Sunscreen lotion Bottle of 60 ml, Clobetasol Propionate Cream 0 pt 05 percent in Tube of 10 gm, Framycetin Sulphate cfream BP 1 percent tube of 20 gm, Hydroquinone 2 percent Tube of 50 gm. , Cap Isotretinoin 20mg, Podophyllin Resin Solution 10 percent, Paraffin soft yellow jar of 4kg, Salicylic Acid Powder, Sisomycin sulphate 0. 10 percent Tube of 7pt5gm, Terbinafine 1percent cream Tube of 10 gm, Triamcinolone Acetate 10 mg 1 ml Inj, Tretinoin 0pt05 percent Tube of 20 gm, Valaciclovir Hcl 500 mg Tab, Clarithromycin 1 percent gel 15 gm tube, Terbinafine Hcl 250 gm Tab, Cream Fusidic Acid 2 percent 10 gm tube, Parachlorbenzene 2 percent wv Benzocaine 2, Povidone Iodine Germicidal Mouth Gargle 2 percent w slash v, Povidone Iodine solution 7 pt 5 100 ml, Enzymatic Detergent solution containing Bacterial Proteases less than 5 percent, Sodium Hypochloride 5 percent Solution, Chlorhexidine gluconate solution equivalent to 4 percent w slash v with Isopropanol less than 10percent, 2-Propranol 45 gm, 1-Propranol 30 gm Ethyl hexadecyl dimethyl ammmonium ethyl sulphate 0. 2gm with skin protecting, Chloroxylenol Solution Potassium Hydroxide 13pt 6 gm Chlaroxylenon solution 50pt 5gm Oleic, Ophthalaldehyde 0 5 or 055 w slash v with test strip, Hydrogen peroxide solution with stabilizer IP Bott of 500 ml, Liquid Antiseptic Chlorhexidine Solution with Activator containing Chlorhexidine Gluconate BP 7pt 5 v slash v Cetrimide BP, Paraformaldehyde Tab, Tab Dutasteride 0 pt 5mg, Tab Frusemide 40 mg, L Ornithine L Asparate Inj 5 gm in Vial slash Amp of 10 ml, L Ornithine L Asparate Powder 5 gm, Bacillus Ciausli 2 billion spores slash 5ml, Ribavirin 200 mg Cap, Tab Chlordiazepoxide 5mg plus Clidinium 2 pt 5mg plus Dicyclomine 10 mg, Human Albumin 20 percent In bott of 100 ml, Somatostatin 3 mg Inj. Quantity: 52004 by. Submission Deadline: 25-11-2024 10: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
POONCH, JAMMU & KASHMIR
Indian Army
Dg Armed Forces Medical Service
Indian Army
RANCHI, JHARKHAND
Indian Army
KANNUR, KERALA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Digoxin 0 pt 5 mg 2 ml Inj | Digoxin 0 pt 5 mg 2 ml Inj | 50 | amp | niyordas92bh | 30 |
| 2 | Vasopressin 20 units slash ml Inj | Vasopressin 20 units slash ml Inj | 75 | amp | niyordas92bh | 30 |
| 3 | Clonidine 100 mcg Tab | Clonidine 100 mcg Tab | 600 | no | niyordas92bh | 30 |
| 4 | Hydrochlorthiazide 25 mg | Hydrochlorthiazide 25 mg | 4,300 | no | niyordas92bh | 30 |
| 5 | Labetalol HCl 20 ml slash 4ml Inj | Labetalol HCl 20 ml slash 4ml Inj | 150 | amp | niyordas92bh | 30 |
| 6 | Phenylephrine 10 mg 1ml Inj | Phenylephrine 10 mg 1ml Inj | 45 | amp | niyordas92bh | 30 |
| 7 | Tab Prazocin 5 mg sustained release slash slow release | Tab Prazocin 5 mg sustained release slash slow release | 1,100 | no | niyordas92bh | 30 |
| 8 | Tab Methylodopa 250mg | Tab Methylodopa 250mg | 300 | no | niyordas92bh | 30 |
| 9 | Metoprolol 12 pt 5mg Tab | Metoprolol 12 pt 5mg Tab | 5,200 | no | niyordas92bh | 30 |
| 10 | Nebivolol 50 mg Tab | Nebivolol 50 mg Tab | 90 | no | niyordas92bh | 30 |
| 11 | Propranolol 20 mg SR Tab | Propranolol 20 mg SR Tab | 2,000 | no | niyordas92bh | 30 |
| 12 | Tab Amlodipine 10mg | Tab Amlodipine 10mg | 14,900 | no | niyordas92bh | 30 |
| 13 | Nicorandl 5 mgTab | Nicorandl 5 mgTab | 500 | no | niyordas92bh | 30 |
| 14 | Triamcinalone Acetate 1 percent for oral use Tube of 5 gm | Triamcinalone Acetate 1 percent for oral use Tube of 5 gm | 240 | tube | niyordas92bh | 30 |
| 15 | Adapalene 0 pt 1 percent Tube of 15 gm | Adapalene 0 pt 1 percent Tube of 15 gm | 660 | tube | niyordas92bh | 30 |
| 16 | 0 pt 05 percent Halobetasol Propionate plus 3 percent Salicylic acid ointment tube of 15 gm | 0 pt 05 percent Halobetasol Propionate plus 3 percent Salicylic acid ointment tube of 15 gm | 180 | tube | niyordas92bh | 30 |
| 17 | Benzylperoxide gel 2pt 5 percent Tube of 20 gms | Benzylperoxide gel 2pt 5 percent Tube of 20 gms | 700 | tube | niyordas92bh | 30 |
| 18 | Lot calamine 8 percent with10 percent light Liquid Paraffin bott of 50ml | Lot calamine 8 percent with10 percent light Liquid Paraffin bott of 50ml | 300 | bott | niyordas92bh | 30 |
| 19 | Betamethasone Dipropionate USP 5mg and Gentamycin Sulphate 1mg slash gm Tube of 5gm | Betamethasone Dipropionate USP 5mg and Gentamycin Sulphate 1mg slash gm Tube of 5gm | 600 | tube | niyordas92bh | 30 |
| 20 | Zinc Oxide slash Titanium Dioxide Bott SPF 50 Sunscreen lotion Bottle of 60 ml | Zinc Oxide slash Titanium Dioxide Bott SPF 50 Sunscreen lotion Bottle of 60 ml | 900 | bott | niyordas92bh | 30 |
| 21 | Clobetasol Propionate Cream 0 pt 05 percent in Tube of 10 gm | Clobetasol Propionate Cream 0 pt 05 percent in Tube of 10 gm | 1,750 | tube | niyordas92bh | 30 |
| 22 | Framycetin Sulphate cfream BP 1 percent tube of 20 gm | Framycetin Sulphate cfream BP 1 percent tube of 20 gm | 1,400 | tube | niyordas92bh | 30 |
| 23 | Hydroquinone 2 percent Tube of 50 gm. | Hydroquinone 2 percent Tube of 50 gm. | 600 | tube | niyordas92bh | 30 |
| 24 | Cap Isotretinoin 20mg | Cap Isotretinoin 20mg | 1,200 | no | niyordas92bh | 30 |
| 25 | Podophyllin Resin Solution 10 percent | Podophyllin Resin Solution 10 percent | 45 | bott | niyordas92bh | 30 |
| 26 | Paraffin soft yellow jar of 4kg | Paraffin soft yellow jar of 4kg | 90 | jar | niyordas92bh | 30 |
| 27 | Salicylic Acid Powder | Salicylic Acid Powder | 9 | kg | niyordas92bh | 30 |
| 28 | Sisomycin sulphate 0.10 percent Tube of 7pt5gm | Sisomycin sulphate 0.10 percent Tube of 7pt5gm | 36 | tube | niyordas92bh | 30 |
| 29 | Terbinafine 1percent cream Tube of 10 gm | Terbinafine 1percent cream Tube of 10 gm | 1,200 | tube | niyordas92bh | 30 |
| 30 | Triamcinolone Acetate 10 mg 1 ml Inj | Triamcinolone Acetate 10 mg 1 ml Inj | 300 | vial | niyordas92bh | 30 |
| 31 | Tretinoin 0pt05 percent Tube of 20 gm | Tretinoin 0pt05 percent Tube of 20 gm | 540 | tube | niyordas92bh | 30 |
| 32 | Valaciclovir Hcl 500 mg Tab | Valaciclovir Hcl 500 mg Tab | 300 | no | niyordas92bh | 30 |
| 33 | Clarithromycin 1 percent gel 15 gm tube | Clarithromycin 1 percent gel 15 gm tube | 150 | tube | niyordas92bh | 30 |
| 34 | Terbinafine Hcl 250 gm Tab | Terbinafine Hcl 250 gm Tab | 2,100 | no | niyordas92bh | 30 |
| 35 | Cream Fusidic Acid 2 percent 10 gm tube | Cream Fusidic Acid 2 percent 10 gm tube | 200 | tube | niyordas92bh | 30 |
| 36 | Parachlorbenzene 2 percent wv Benzocaine 2 | Parachlorbenzene 2 percent w/v Benzocaine 2 pt 7 percent w slash v Chlorbutol 5 percent Turpentine oil 25 percent w slash v bott of 10 ml | 900 | bott | niyordas92bh | 30 |
| 37 | Povidone Iodine Germicidal Mouth Gargle 2 percent w slash v | Povidone Iodine Germicidal Mouth Gargle 2 percent w slash v | 900 | bott | niyordas92bh | 30 |
| 38 | Povidone Iodine solution 7 pt 5 100 ml | Povidone Iodine solution 7 pt 5 100 ml | 780 | bott | niyordas92bh | 30 |
| 39 | Enzymatic Detergent solution containing Bacterial Proteases less than 5 percent | Enzymatic Detergent solution containing Bacterial Proteases less than 5 percent Alpha Amylase less than 5 percent Lipase less than 5 percent Cellulose less than 5percent sodium tetrabroated decahydarte less than 8pt5 percent per 100 Can of 3 pt78 Litre | 21 | can | niyordas92bh | 30 |
| 40 | Sodium Hypochloride 5 percent Solution | Sodium Hypochloride 5 percent Solution | 450 | ltr | niyordas92bh | 30 |
| 41 | Chlorhexidine gluconate solution equivalent to 4 percent w slash v with Isopropanol less than 10percent | Chlorhexidine gluconate solution equivalent to 4 percent w slash v with Isopropanol less than 10percent Ethoxylated alkylphenol less than 10 percent Fatty acid diethanolamide les than10 percent Acetic acid glacial less than10 percent Cellulose and fragnance less than10 percent 500 ml Bott with dispenser 500ml per | 120 | bott | niyordas92bh | 30 |
| 42 | 2-Propranol 45 gm,1-Propranol 30 gm Ethyl hexadecyl dimethyl ammmonium ethyl sulphate 0.2gm with skin protecting | 2-Propranol 45 gm,1-Propranol 30 gm Ethyl hexadecyl dimethyl ammmonium ethyl sulphate 0.2gm with skin protecting substances 500 ml bott with dispenser | 900 | bott | niyordas92bh | 30 |
| 43 | Chloroxylenol Solution Potassium Hydroxide 13pt 6 gm Chlaroxylenon solution 50pt 5gm Oleic | Chloroxylenol Solution Potassium Hydroxide 13pt 6 gm Chlaroxylenon solution 50pt 5gm Oleic acid 7pt 5ml Castor oil 63pt 0gm terpineal 100 ml Ethanol 96% 200 ml purified water Freshly boiled & cooled to produce 1000 ml also acceptabl Chloraxylenol 4pt 5 5 pt 5 | 450 | ltr | niyordas92bh | 30 |
| 44 | Ophthalaldehyde 0 5 or 055 w slash v with test strip | Ophthalaldehyde 0 5 or 055 w slash v with test strip | 80 | ltr | niyordas92bh | 30 |
| 45 | Hydrogen peroxide solution with stabilizer IP Bott of 500 ml | Hydrogen peroxide solution with stabilizer IP Bott of 500 ml | 270 | bott | niyordas92bh | 30 |
| 46 | Liquid Antiseptic Chlorhexidine Solution with Activator containing Chlorhexidine Gluconate BP 7pt 5 v slash v Cetrimide BP | Liquid Antiseptic Chlorhexidine Solution with Activator containing Chlorhexidine Gluconate BP 7pt 5 v slash v Cetrimide BP 15 percent w slash v sufficient quantity of Tab sodium Nitrite 1g to make 0pt 4 percent Soln with each 500ml cont in air tight pack Savlon | 90 | bott | niyordas92bh | 30 |
| 47 | Paraformaldehyde Tab | Paraformaldehyde Tab | 800 | no | niyordas92bh | 30 |
| 48 | Tab Dutasteride 0 pt 5mg | Tab Dutasteride 0 pt 5mg | 500 | no | niyordas92bh | 30 |
| 49 | Tab Frusemide 40 mg | Tab Frusemide 40 mg | 1,500 | no | niyordas92bh | 30 |
| 50 | L Ornithine L Asparate Inj 5 gm in Vial slash Amp of 10 ml | L Ornithine L Asparate Inj 5 gm in Vial slash Amp of 10 ml | 75 | amp | niyordas92bh | 30 |
| 51 | L Ornithine L Asparate Powder 5 gm | L Ornithine L Asparate Powder 5 gm | 100 | sachet | niyordas92bh | 30 |
| 52 | Bacillus Ciausli 2 billion spores slash 5ml | Bacillus Ciausli 2 billion spores slash 5ml | 800 | bott | niyordas92bh | 30 |
| 53 | Ribavirin 200 mg Cap | Ribavirin 200 mg Cap | 300 | no | niyordas92bh | 30 |
| 54 | Tab Chlordiazepoxide 5mg plus Clidinium 2 pt 5mg plus Dicyclomine 10 mg | Tab Chlordiazepoxide 5mg plus Clidinium 2 pt 5mg plus Dicyclomine 10 mg | 100 | no | niyordas92bh | 30 |
| 55 | Human Albumin 20 percent In bott of 100 ml | Human Albumin 20 percent In bott of 100 ml | 52 | bott | niyordas92bh | 30 |
| 56 | Somatostatin 3 mg Inj | Somatostatin 3 mg Inj | 6 | amp | niyordas92bh | 30 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Additional Doc 2 (Requested in ATC)
Additional Doc 3 (Requested in ATC)
Additional Doc 4 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
To participate in the tender process, the eligibility requirements include being a registered entity in the pharmaceuticals sector, having demonstrable past performance, and meeting the specified experience criteria as outlined in the documents. Bidders must also provide all required compliance documents related to drug quality standards.
Bidders must provide several certificates, including OEM authorization, compliance certificates related to the specific medications, and any additional certificates as required in the ATC. These documents are crucial to demonstrate alignment with technical specifications and quality standards.
To register for the tender, bidders must fulfill all applicable registration regulations pertinent to the pharmaceuticals industry in India. They must then submit the necessary documentation and proposals through the designated tender portal, adhering to all outlined submission formats.
Accepted document formats generally include PDF for the main submissions, alongside any supporting documents that may be required in appropriate formats as specified by the buyer in the ATC. Bidders must ensure clarity and legibility in all documents submitted.
Bidders must adhere to stringent technical specifications as detailed in the Bill of Quantities (BoQ). This includes various medications outlined in the tender documents, requiring bidders to provide accurate and comprehensive descriptions and compliance evidence.
All products offered must comply with the essential quality standards required for pharmaceuticals, including ensuring proper stability, efficacy, and safety, as per Indian regulatory standards. Bidders should include relevant compliance documentation in their submissions.
Compliance requirements entail adhering to all specifications outlined in the tender documents, including the provision of appropriate certifications, documentation, and detailed descriptions of products offered. Suppliers must also have previous successful experience in providing similar products.
The Earnest Money Deposit (EMD) details will be specified in the tender documentation. Bidders must ensure compliance with the stipulated requirements to secure their tender applications.
Successful bidders may be required to furnish performance security as part of the procurement process. The value and specifics regarding this security will be detailed in the award documentation, ensuring that suppliers can satisfactorily fulfill contract terms.
Payment terms for the tender are usually stated in the tender documents. Bidders should clarify these terms carefully, validating how and when payments will be processed upon successful delivery of products.
Price evaluation considerations focus on competitive pricing while ensuring compliance with technical requirements. The evaluation will concentrate on lowest-priced technically qualified bids, balancing both cost and quality.
Bids can typically be submitted through the designated tender portal, ensuring that all required documents and entities' information are complete. Failure to comply with submission instructions may lead to disqualification.
While specific dates are excluded, bidders must prepare for crucial timelines related to submission deadlines and bid-opening intervals as per official tender schedules.
The evaluation and selection process comprises stringent assessment criteria, primarily focusing on technical qualification followed by pricing. Bidders presenting the lowest quotes compliant with all technical specifications will be prioritized.
Once evaluations conclude, bidders will be notified of the results via the official communication channels specified in the tender documents, providing clarity on the outcome.
While the tender does not explicitly outline benefits for Micro, Small, and Medium Enterprises (MSEs), it supports local procurement initiatives aligned with Indian governmental schemes aimed at encouraging domestic manufacturing and supply.
The current tender does not mention specific provisions for startups. However, supportive measures may be referenced in the broader regulatory framework aimed at fostering Indian enterprises within the pharmaceutical sector.
The tender emphasizes the ‘Make in India’ initiative by prioritizing local manufacturers, aiming to source products domestically to reduce reliance on imports and enhance self-sufficiency in pharmaceuticals for defense requirements.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS